Cognex director exercises 2,913 RSUs into shares

COGNEX CORP director Sachin Lawande exercised restricted stock units into common shares.

Rhea-AI Filing Summary

COGNEX CORP director Sachin Lawande exercised restricted stock units into common shares. On February 21, 2026, he converted 2,913 restricted stock units into 2,913 shares of Cognex common stock at $0.00 per share through a derivative exercise.

After this transaction, he directly held 28,431 shares of common stock and 4,817 restricted stock units. Each restricted stock unit represents a right to receive one share of Cognex common stock, and these units vest 20%, 30%, and 50% on the first, second, and third anniversaries of the February 21, 2023 grant date.

Insider Trade Summary

2,913 shares exercised/converted

Exercise 3 txns

Insider Lawande Sachin

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	2,913	$0.00	$0.00
Exercise	Common Stock	2,913	$0.00	$0.00
holding	Restricted Stock Unit	--	--	--

Holdings After Transaction: Restricted Stock Unit — 4,817 contracts (Direct); Common Stock — 28,431 shares (Direct)

Footnotes (2)

1. F1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.
2. F2. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Cognex (CGNX) director Sachin Lawande report in this Form 4?

Sachin Lawande reported exercising 2,913 restricted stock units into 2,913 shares of Cognex common stock. The derivative exercise occurred on February 21, 2026, at $0.00 per share and reflects routine equity compensation activity rather than an open-market stock purchase or sale.

How many Cognex (CGNX) shares does Sachin Lawande hold after the reported transactions?

After the reported exercise, Sachin Lawande directly holds 28,431 shares of Cognex common stock. In addition, he holds 4,817 restricted stock units, each representing a right to receive one Cognex share upon vesting under the terms of his equity award agreement.

What type of security did Sachin Lawande convert in the Cognex (CGNX) Form 4?

He converted restricted stock units into common stock of Cognex Corporation. Specifically, 2,913 restricted stock units were exercised or converted, resulting in the issuance of 2,913 shares of Cognex common stock at a stated transaction price of $0.00 per share.

How do Sachin Lawande’s Cognex (CGNX) restricted stock units vest?

The restricted stock units vest in three stages over three years from the February 21, 2023 grant date. Vesting occurs approximately 20% on the first anniversary, 30% on the second anniversary, and 50% on the third anniversary, subject to the award’s standard conditions.

Was this Cognex (CGNX) Form 4 a stock purchase or sale by Sachin Lawande?

The Form 4 reflects a derivative exercise, not an open-market purchase or sale. Code “M” indicates the exercise or conversion of restricted stock units into common stock, with 2,913 units converting into 2,913 shares at a $0.00 per share transaction price.

What does each Cognex (CGNX) restricted stock unit represent for Sachin Lawande?

Each restricted stock unit represents a contingent right to receive one share of Cognex common stock. Delivery of shares depends on vesting conditions tied to the award, with installments vesting over three years from the February 21, 2023 grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/24/2026 - 04:48 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Lawande Sachin

(Last) (First) (Middle)

ONE VISION DRIVE

(Street)

NATICK MA 01760

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
COGNEX CORP [ CGNX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/21/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/21/2026		M		2,913	A	$0.0	28,431	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	$0.0(1)	02/21/2026		M			2,913	02/21/2024(2)	02/21/2026	Common Stock	2,913	$0.0	0	D
Restricted Stock Unit	$0.0							02/17/2027	02/17/2027	Common Stock	4,817		4,817	D

Explanation of Responses:

1. Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

2. The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.

	Sachin Lawande	02/24/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.